Insights

Recent Acquisitions Neogene Therapeutics has been recently acquired by AstraZeneca, indicating potential synergies for cross-selling opportunities and access to a broader customer base within the AstraZeneca network.

Strategic Partnerships The strategic partnership between Neogene Therapeutics and Twist Bioscience opens doors for collaborative sales initiatives, leveraging combined expertise to target a wider market segment for personalized cancer therapies.

Clinical Trial Launch Following the launch of a clinical trial application, Neogene Therapeutics offers a prime opportunity for sales representatives to engage with healthcare providers and oncologists seeking innovative TCR therapies for treating advanced solid tumors.

Key Personnel Addition The recent hire of Dr. Raphaël Rousseau as Chief Medical Officer signifies an opportunity for sales teams to align with a seasoned industry expert, potentially facilitating introductions to key opinion leaders and decision-makers in the field of T cell therapies.

Market Expansion with NCI Partnership Partnership with the National Cancer Institute broadens Neogene's market reach and presents avenues for sales professionals to engage with institutions and research centers looking to adopt cutting-edge TCR therapies targeting specific cancer mutations.

Neogene Therapeutics Tech Stack

Neogene Therapeutics uses 8 technology products and services including Power BI, Font Awesome, jQuery Migrate, and more. Explore Neogene Therapeutics's tech stack below.

  • Power BI
    Business Intelligence
  • Font Awesome
    Font Scripts
  • jQuery Migrate
    Javascript Libraries
  • RSS
    Miscellaneous
  • Open Graph
    Miscellaneous
  • Cisco Meraki
    Network Hardware
  • iOS
    Programming Languages
  • Minitab
    Visualisation Software

Media & News

Neogene Therapeutics's Email Address Formats

Neogene Therapeutics uses at least 1 format(s):
Neogene Therapeutics Email FormatsExamplePercentage
First.Last@neogene.comJohn.Doe@neogene.com
92%
FL@neogene.comJD@neogene.com
3%
First.Last@neogene.comJohn.Doe@neogene.com
3%
First.L@neogene.comJohn.D@neogene.com
2%

Frequently Asked Questions

Where is Neogene Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Neogene Therapeutics's main headquarters is located at Science Park 106 Amsterdam, North Holland 1098 NL. The company has employees across 2 continents, including EuropeNorth America.

What is Neogene Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Neogene Therapeutics's official website is neogene.com and has social profiles on LinkedIn.

How much revenue does Neogene Therapeutics generate?

Minus sign iconPlus sign icon
As of August 2024, Neogene Therapeutics's annual revenue reached $15M.

What is Neogene Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Neogene Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Neogene Therapeutics have currently?

Minus sign iconPlus sign icon
As of August 2024, Neogene Therapeutics has approximately 191 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer & Co-Founder: C. L.Vice President And Head Of Information Technology: H. M.Vice President Supply Chain: C. C.. Explore Neogene Therapeutics's employee directory with LeadIQ.

What industry does Neogene Therapeutics belong to?

Minus sign iconPlus sign icon
Neogene Therapeutics operates in the Biotechnology Research industry.

What technology does Neogene Therapeutics use?

Minus sign iconPlus sign icon
Neogene Therapeutics's tech stack includes Power BIFont AwesomejQuery MigrateRSSOpen GraphCisco MerakiiOSMinitab.

What is Neogene Therapeutics's email format?

Minus sign iconPlus sign icon
Neogene Therapeutics's email format typically follows the pattern of . Find more Neogene Therapeutics email formats with LeadIQ.

How much funding has Neogene Therapeutics raised to date?

Minus sign iconPlus sign icon
As of August 2024, Neogene Therapeutics has raised $110M in funding. The last funding round occurred on Sep 14, 2020.

When was Neogene Therapeutics founded?

Minus sign iconPlus sign icon
Neogene Therapeutics was founded in 2018.
Neogene Therapeutics

Neogene Therapeutics

Biotechnology ResearchNorth Holland, Netherlands51-200 Employees

Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR) therapies targeting a broad spectrum of solid cancers. With offices in Santa Monica, CA and Amsterdam, the Netherlands, Neogene is aiming to change the paradigm of treatment for solid cancers. Neogene is a member of the AstraZeneca Group.

Section iconCompany Overview

Headquarters
Science Park 106 Amsterdam, North Holland 1098 NL
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $110M

    Neogene Therapeutics has raised a total of $110M of funding over 2 rounds. Their latest funding round was raised on Sep 14, 2020.

  • $10M$50M

    Neogene Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $110M

    Neogene Therapeutics has raised a total of $110M of funding over 2 rounds. Their latest funding round was raised on Sep 14, 2020.

  • $10M$50M

    Neogene Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.